美国输液药物市场规模、份额、趋势分析报告：按类型、营养和细分市场预测，2024-2030 年

美国输液药物市场成长与趋势：

根据Grand View Research, Inc.最新报告显示，到2030年，美国静脉输液市场规模预计将达79亿美元，2024年至2030年复合年增长率为7.8%。

由于疾病盛行率上升和手术数量增加，市场出现成长。此外，不断增加的老年人口更容易罹患癌症、神经病变、心血管疾病和脊椎损伤等非传染性疾病，可能会影响市场成长。

越来越多的医院、门诊手术中心、输液中心、医疗水疗中心等正在促进市场成长。根据门诊手术中心协会公布的资料，2022年美国共有6,087个门诊手术中心，其中加州最多（848个），其次是佛罗里达州（468个）。

静脉补水疗法是治疗严重脱水的一种非常有效的治疗方法。患有某些慢性疾病（例如糖尿病和某些肾臟疾病）的人可能面临更高的脱水风险。水合疗法有助于恢復体内适当的电解质平衡。最常用的静脉注射治疗是含有水和氯化钠的简单生理食盐水。然而，也经常使用含有糖（例如葡萄糖、右旋糖和左旋糖）的溶液。例如，领先的输液治疗和输液技术公司 Baxter 与西北医学院合作，于 2023 年 12 月完成了静脉注射袋回收试验计画的初始阶段。这项倡议从垃圾掩埋场转移了超过 6 吨 PVC IV 袋废弃物。如果端到端铺设，这个数量可以覆盖整个芝加哥，从而促进环境上永续的再利用。

美国静脉注射市场报告亮点

• 按类型划分，由于慢性病的增加及其治疗需要手术，综合肠外营养细分市场在 2023 年以 67.02% 的最大销售份额引领市场。
• 从营养成分来看，维生素和矿物质（盐和电解质）领域预计在预测期内将以 10.0% 的复合年增长率增长最快。
• 从营养成分来看，单剂量胺基酸细分市场处于领先地位，2023 年销售份额最大，为 31.27%。
• 2020 年 9 月，百特获得美国FDA核准，开发其产品 Clinimix 的新配方，以更少的葡萄糖提供更多的蛋白质。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章美国输液药物市场变数、趋势与范围

• 市场体系展望
  • 母市场展望
  • 相关/附随市场展望
• 市场动态
  • 市场推动要素分析
  • 市场限制因素分析
• 美国输液药物市场分析工具
  • 产业分析-波特五力分析
  • PESTEL分析

第四章美国输液药品市场：类型估计与趋势分析

• 2023年及2030年产品市场占有率
• 细分仪表板
• 美国输液药物市场：按类型分類的前景
• 2018-2030年市场规模、预测及趋势分析
• 高热量输液
• 週边肠外营养

第五章美国输液药品市场：营养估算及趋势分析

• 2023年及2030年营养品市场占有率
• 细分仪表板
• 美国输液市场：美国营养品展望
• 2018-2030年市场规模、预测及趋势分析
• 碳水化合物
• 单剂量胺基酸
• 维生素和矿物质
• 肠外脂肪乳
• 其他的

第六章 竞争状况

• 主要市场参与企业的最新趋势和影响分析
• 公司/竞争对手分类
• 供应商情况
• 公司简介
  • Fresenius Kabi AG
  • Pfizer Inc.
  • Baxter
  • ICU Medical
  • Option Care Health Inc.
  • B. Braun Medical Inc

U.S. Intravenous Solutions Market Growth & Trends:

The U.S. intravenous solutions market size is anticipated to reach USD 7.90 billion by 2030 and is projected to grow at a CAGR of 7.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is observed due to the rising prevalence of diseases, and the increasing number of surgeries. In addition, the rising number of geriatric population susceptible to non-communicable diseases such as cancer, neurological disorders, cardiovascular disorders, and spinal injuries is likely to impact market growth.

The increasing number of hospitals, ambulatory surgical centers, intravenous (IV) solutions infusion centers, and med spas contribute to the market growth. According to the data published by the Ambulatory Surgery Center Association, the number of ambulatory surgery centers in the U.S. in 2022 was 6087, out of which California state had the highest number (848), followed by Florida state (468).

IV hydration therapy is a highly effective treatment for severe dehydration. Individuals with certain chronic illnesses, such as diabetes or certain kidney conditions, may be at a greater risk of dehydration. Rehydration therapy helps to restore the proper electrolyte balance in the body. The most commonly used IV treatment is a simple saline solution that contains water and sodium chloride. However, solutions containing sugar, such as glucose, dextrose, or levulose, are also frequently used. For instance, in December 2023, Baxter, a prominent figure in infusion therapies and technologies, completed the initial phase of its pilot program for IV bag recycling with Northwestern Medicine. This effort has diverted over six tons of PVC IV bag waste from landfills. This amount could stretch across Chicago if laid end-to-end, promoting environmentally sustainable reuse.

U.S. Intravenous Solutions Market Report Highlights:

• Based on type, the total parenteral nutrition segment led the market with the largest revenue share of 67.02% in 2023, owing to the increased number of chronic disorders and the surgeries need to treat them
• Based on nutrients, the vitamins and minerals (salt and electrolyte) segment is expected to grow at the fastest CAGR of 10.0% over the forecast period
• Based on nutrients, The single dose amino acids segment led the market with the largest revenue share 31.27% in 2023
• In September 2020, Baxter got the U.S. FDA approval to develop new formulations of its product Clinimix to provide more protein while delivering less dextrose

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Nutrients
  • 1.2.3. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Nutrients outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Intravenous Solutions Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. U.S. Intravenous Solutions Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Intravenous Solutions Market: Type Estimates & Trend Analysis

• 4.1. Product Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. U.S. Intravenous Solutions Market by Type Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Total Parenteral Nutrition (TPN)
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.4.2. Peripheral Parenteral Nutrition (PPN)
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. U.S. Intravenous Solutions Market: Nutrients Estimates & Trend Analysis

• 5.1. Nutrients Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. U.S. Intravenous Solutions Market by Nutrients Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Carbohydrates
    • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.4.2. Single dose amino acids
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.4.3. Vitamins and minerals
    • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.4.4. Parenteral lipid emulsion
    • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.4.5. Others
    • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/Competition Categorization
• 6.3. Vendor Landscape
  • 6.3.1. List of key distributors and channel partners
  • 6.3.2. Key customers
  • 6.3.3. Key company heat map analysis, 2023
• 6.4. Company Profiles
  • 6.4.1. Fresenius Kabi AG
    • 6.4.1.1. Company overview
    • 6.4.1.2. Financial performance
    • 6.4.1.3. Product benchmarking
    • 6.4.1.4. Strategic initiatives
  • 6.4.2. Pfizer Inc.
    • 6.4.2.1. Company overview
    • 6.4.2.2. Financial performance
    • 6.4.2.3. Product benchmarking
    • 6.4.2.4. Strategic initiatives
  • 6.4.3. Baxter
    • 6.4.3.1. Company overview
    • 6.4.3.2. Financial performance
    • 6.4.3.3. Product benchmarking
    • 6.4.3.4. Strategic initiatives
  • 6.4.4. ICU Medical
    • 6.4.4.1. Company overview
    • 6.4.4.2. Financial performance
    • 6.4.4.3. Product benchmarking
    • 6.4.4.4. Strategic initiatives
  • 6.4.5. Option Care Health Inc.
    • 6.4.5.1. Company overview
    • 6.4.5.2. Financial performance
    • 6.4.5.3. Product benchmarking
    • 6.4.5.4. Strategic initiatives
  • 6.4.6. B. Braun Medical Inc
    • 6.4.6.1. Company overview
    • 6.4.6.2. Financial performance
    • 6.4.6.3. Product benchmarking
    • 6.4.6.4. Strategic initiatives

List of Tables

• Table 1. List of abbreviations
• Table 2. U.S. Intravenous solutions market, by type, 2018 - 2030 (USD Billion)
• Table 3. U.S. Intravenous solutions market, by type, 2018 - 2030 (Thousand Units)
• Table 4. U.S. Intravenous solutions market, by nutrients, 2018 - 2030 (USD Billion)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 U.S. intravenous solutions market: market outlook
• Fig. 9 U.S. intravenous solutions competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 U.S. intravenous solutions market driver impact
• Fig. 14 U.S. intravenous solutions market restraint impact
• Fig. 15 U.S. intravenous solutions: Type movement analysis
• Fig. 16 U.S. intravenous solutions: Type outlook and key takeaways
• Fig. 17 Total parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 18 Peripheral parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 19 U.S. intravenous solutions: Nutrients movement analysis
• Fig. 20 U.S. intravenous solutions: Nutrients outlook and key takeaways
• Fig. 21 Carbohydrates market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 22 Single dose amino acids market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 23 Vitamins and minerals market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 24 Parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Billion)